期刊
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
卷 103, 期 3, 页码 102-111出版社
WILEY
DOI: 10.1111/iep.12440
关键词
hepatocellular carcinoma; lncRNA MIAT; miR-411-5p; PD-L1; STAT3
类别
资金
- National Natural Science Foundation of China [82173167]
- Startup Fund for Scientific Research of the Fujian Medical University [2019XQ2020]
- Joint Funds for the Innovation of Science and Technology, Fujian Province [2017Y9100]
- Natural Science Foundation of Fujian Province [2018J01296]
The long noncoding RNA MIAT plays a crucial role in the immune escape of hepatocellular carcinoma (HCC) by regulating the miR-411-5p/STAT3/PD-L1 pathway. MIAT suppresses miR-411-5p expression, upregulates STAT3, and ultimately enhances PD-L1 expression, facilitating immune evasion of HCC cells.
Emerging evidences have shown that long noncoding RNA (lncRNA) plays an important role in the immune escape of cancer cells. Our previous study has demonstrated that lncRNA MIAT is associated with the immune infiltration of hepatocellular carcinoma (HCC). However, the underlying mechanism of MIAT regulating the PD-L1-mediated immune escape of HCC is poorly understood. Quantitative real-time PCR (qRT-PCR) was used to detect the expression of MIAT and PD-L1 mRNA in HCC. The relationship between MIAT, miR-411-5p, STAT3 and PD-L1 was explored by dual-luciferase reporter assay, cytotoxicity assay, Western blot and RNA immunoprecipitation (RIP). In addition, the xenograft model was established to determine the effect of MIAT on PD-L1 expression in vivo. We found that MIAT and PD-L1 were significantly upregulated in HCC tissues and the expression of PD-L1 was regulated by MIAT. The knockdown of MIAT enhanced the cytotoxicity of T cells on HCC cells. MIAT negatively regulated miR-411-5p expression, upregulated STAT3 and ultimately increased PD-L1 expression from the transcription level. The inhibition of miR-411-5p reversed STAT3 and PD-L1 expression inhibited by MIAT knockdown in HCC cells. This study suggests a novel lncRNA-mediated mechanism for HCC cells to evade the immune response; MIAT/miR-411-5p/STAT3/PD-L1 may be a novel therapeutic target for HCC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据